Target Name: MIR564
NCBI ID: G693149
Review Report on MIR564 Target / Biomarker Content of Review Report on MIR564 Target / Biomarker
MIR564
Other Name(s): hsa-miR-564 | hsa-mir-564 | MicroRNA 564 | microRNA 564 | MIRN564

MIR564: A Non-Coding RNA Molecule as A Potential Drug Target and Biomarker

MIR564, also known as hsa-miR-564, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to study, and various studies have shown that MIR564 can be modulated by various therapeutic approaches, including drug treatments.

MIR564 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in a variety of tissues and cells and can interact with various cellular components to regulate gene expression. The expression pattern of MIR564 is highly dynamic and can be modulated by various factors, including growth factors, DNA methylation, and drug treatments.

One of the key features of MIR564 is its expression pattern. It is highly expressed in various tissues, including the brain, heart, and liver, and is also expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Its expression pattern is also modulated by various factors, including growth factors, DNA methylation, and drug treatments. This makes MIR564 an attractive target for studying the effects of drugs on cancer progression and treatment response.

In addition to its expression pattern, MIR564 has also been shown to play a role in cellular signaling pathways. It has been shown to interact with various cellular signaling pathways, including the PI3K/Akt signaling pathway, the TGF-β signaling pathway, and the NF-kappa-B signaling pathway. It is also involved in the regulation of various cellular processes, including cell adhesion, migration, and apoptosis.

The potential drug targets for MIR564 are vast and varied. Its expression pattern and interactions with various cellular signaling pathways make it an attractive target for drugs that can modulate its expression and activity. Some potential drug targets for MIR564 include small molecules, such as inhibitors of the PI3K/Akt signaling pathway, as well as large molecules, such as anti-inflammatory drugs or immunomodulators.

In addition to its potential as a drug target, MIR564 has also been shown to be a valuable biomarker for various diseases. Its expression pattern is modulated by various factors, including growth factors, DNA methylation, and drug treatments. This makes it an attractive target for studying the effects of drugs on disease progression and treatment response.

In conclusion, MIR564 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and expression pattern make it an attractive target for researchers to study, and various studies have shown that MIR564 can be modulated by various therapeutic approaches. Further research is needed to fully understand the potential of MIR564 as a drug target and biomarker, and to develop effective treatments for various diseases.

Protein Name: MicroRNA 564

The "MIR564 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR564 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088